Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort.

Chipps BE, Zeiger RS, Dorenbaum A, Borish L, Wenzel SE, Miller DP, Hayden ML, Bleecker ER, Simons FE, Szefler SJ, Weiss ST, Haselkorn T; TENOR Study Group.

Curr Respir Care Rep. 2012 Dec;1(4):259-269. Epub 2012 Sep 20.

2.

Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma.

Dolan CM, Fraher KE, Bleecker ER, Borish L, Chipps B, Hayden ML, Weiss S, Zheng B, Johnson C, Wenzel S; TENOR Study Group.

Ann Allergy Asthma Immunol. 2004 Jan;92(1):32-9.

PMID:
14756462
3.

Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.

Chipps BE, Zeiger RS, Borish L, Wenzel SE, Yegin A, Hayden ML, Miller DP, Bleecker ER, Simons FE, Szefler SJ, Weiss ST, Haselkorn T; TENOR Study Group.

J Allergy Clin Immunol. 2012 Aug;130(2):332-42.e10. doi: 10.1016/j.jaci.2012.04.014. Epub 2012 Jun 12.

4.

More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II.

Chipps BE, Haselkorn T, Paknis B, Ortiz B, Bleecker ER, Kianifard F, Foreman AJ, Szefler SJ, Zeiger RS; Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens Study Group.

J Allergy Clin Immunol. 2017 Aug 7. pii: S0091-6749(17)31270-8. doi: 10.1016/j.jaci.2017.07.014. [Epub ahead of print]

PMID:
28797732
5.

Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.

Haselkorn T, Fish JE, Zeiger RS, Szefler SJ, Miller DP, Chipps BE, Simons FE, Weiss ST, Wenzel SE, Borish L, Bleecker ER; TENOR Study Group.

J Allergy Clin Immunol. 2009 Nov;124(5):895-902.e1-4. doi: 10.1016/j.jaci.2009.07.035. Epub 2009 Oct 7.

PMID:
19811812
6.

Asthma in older adults: observations from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study.

Slavin RG, Haselkorn T, Lee JH, Zheng B, Deniz Y, Wenzel SE; TENOR Study Group.

Ann Allergy Asthma Immunol. 2006 Mar;96(3):406-14.

PMID:
16597074
7.

Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation.

Norman G, Faria R, Paton F, Llewellyn A, Fox D, Palmer S, Clifton I, Paton J, Woolacott N, McKenna C.

Health Technol Assess. 2013 Nov;17(52):1-342. doi: 10.3310/hta17520. Review.

8.

Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthma.

Luskin AT, Chipps BE, Rasouliyan L, Miller DP, Haselkorn T, Dorenbaum A.

J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):544-52.e1-2. doi: 10.1016/j.jaip.2014.02.011. Epub 2014 Jul 3.

PMID:
25213047
9.

Asthma Exacerbations and Triggers in Children in TENOR: Impact on Quality of Life.

Chipps BE, Haselkorn T, Rosén K, Mink DR, Trzaskoma BL, Luskin AT.

J Allergy Clin Immunol Pract. 2017 Aug 9. pii: S2213-2198(17)30422-1. doi: 10.1016/j.jaip.2017.05.027. [Epub ahead of print]

10.

Allergy, total serum immunoglobulin E, and airflow in children and adolescents in TENOR.

Haselkorn T, Szefler SJ, Simons FE, Zeiger RS, Mink DR, Chipps BE, Borish L, Wong DA; TENOR Study Group.

Pediatr Allergy Immunol. 2010 Dec;21(8):1157-65. doi: 10.1111/j.1399-3038.2010.01065.x.

PMID:
20444153
11.

TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma.

Miller MK, Lee JH, Blanc PD, Pasta DJ, Gujrathi S, Barron H, Wenzel SE, Weiss ST; TENOR Study Group.

Eur Respir J. 2006 Dec;28(6):1145-55. Epub 2006 Jul 26.

12.

Effect of weight change on asthma-related health outcomes in patients with severe or difficult-to-treat asthma.

Haselkorn T, Fish JE, Chipps BE, Miller DP, Chen H, Weiss ST.

Respir Med. 2009 Feb;103(2):274-83. doi: 10.1016/j.rmed.2008.08.010. Epub 2008 Sep 25.

13.

Asthma in the United States: recent trends and current status.

Sullivan SD.

J Manag Care Pharm. 2003 Sep-Oct;9(5 Suppl):3-7. Review.

14.

Clinical burden and predictors of asthma exacerbations in patients on guideline-based steps 4-6 asthma therapy in the TENOR cohort.

Calhoun WJ, Haselkorn T, Mink DR, Miller DP, Dorenbaum A, Zeiger RS.

J Allergy Clin Immunol Pract. 2014 Mar-Apr;2(2):193-200. doi: 10.1016/j.jaip.2013.11.013.

PMID:
24607048
15.

Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma.

Schatz M, Hsu JW, Zeiger RS, Chen W, Dorenbaum A, Chipps BE, Haselkorn T.

J Allergy Clin Immunol. 2014 Jun;133(6):1549-56. doi: 10.1016/j.jaci.2013.10.006. Epub 2013 Dec 4.

PMID:
24315502
16.

Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations.

Zeiger RS, Yegin A, Simons FE, Haselkorn T, Rasouliyan L, Szefler SJ, Chipps BE; TENOR Study Group.

Ann Allergy Asthma Immunol. 2012 Feb;108(2):81-7. doi: 10.1016/j.anai.2011.12.001.

PMID:
22289725
17.

Gender differences in IgE-mediated allergic asthma in the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study.

Lee JH, Haselkorn T, Chipps BE, Miller DP, Wenzel SE; Tenor Study Group.

J Asthma. 2006 Apr;43(3):179-84.

PMID:
16754518
18.

Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma.

Borish L, Chipps B, Deniz Y, Gujrathi S, Zheng B, Dolan CM; TENOR Study Group.

Ann Allergy Asthma Immunol. 2005 Sep;95(3):247-53.

PMID:
16200815
19.

Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients.

Sullivan SD, Wenzel SE, Bresnahan BW, Zheng B, Lee JH, Pritchard M, Kamath TV, Weiss ST; TENOR Study Group.

Allergy. 2007 Jun;62(6):655-60.

20.

The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.

Walter H, Sadeque-Iqbal F, Ulysse R, Castillo D, Fitzpatrick A, Singleton J.

JBI Database System Rev Implement Rep. 2015 Oct;13(10):69-81. doi: 10.11124/jbisrir-2015-2335.

PMID:
26571284

Supplemental Content

Support Center